Evidence map›Paper›PMID 25481917›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2015

Reasons for Electronic Cigarette Experimentation and Discontinuation Among Adolescents and Young Adults.

Grace Kong, Meghan E Morean, Dana A Cavallo, Deepa R Camenga, Suchitra Krishnan-Sarin

Abstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 388 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
388citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

388 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Tailoring e-Cigarette Health Messages by Vaping Status: How Source and Message Presentation Type Shape Young Adults' Perceptions.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Impact of Financial Disclosures and Health Warnings on Youth and Young Adult Perceptions of Pro-E-cigarette Instagram Posts.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Trial
  14. The effects of inhaled flavors on intravenous nicotine.Experimental and clinical psychopharmacology · 2021
    Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. Why Adolescents Choose to Stop or Never Start Vaping: Evidence From South Africa.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article

328 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Grace KongDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT; grace.kong@yale.edu.
Meghan E MoreanDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT;
Dana A CavalloDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT;
Deepa R CamengaDepartment of Pediatrics, Yale University School of Medicine, New Haven, CT.
Suchitra Krishnan-SarinDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT;

Funding

TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1994 to 2018
$40.5M
Research Training Program in Substance Use PreventionT32DA019426 · NIDA · YALE UNIVERSITY · PI TAMI P SULLIVAN · 2005 to 2026
$7.5M
NIDA NIH HHS 1K12DA033012-01A1NIDA NIH HHS P50DA009241NIDA NIH HHS T32DA019426
6 · The paper itself

Abstract

introductionUnderstanding why young people try and stop electronic cigarette (e-cigarette) use is critical to inform e-cigarette regulatory efforts.

methodsWe conducted 18 focus groups (N = 127) in 1 middle school (MS), 2 high schools (HSs), and 2 colleges in Connecticut to assess themes related to e-cigarette experimentation and discontinuation. We then conducted surveys to evaluate these identified themes in 2 MSs, 4 HSs, and 1 college (N = 1,175) to explore whether reasons for e-cigarette experimentation and/or discontinuation differed by school level or cigarette smoking status.

resultsFrom the focus groups, we identified experimentation themes (i.e., curiosity, flavors, family/peer influence, easy access, and perceptions of e-cigarettes as "cool" and as a healthier/better alternative to cigarettes) and discontinuation themes (i.e., health concerns, loss of interest, high cost, bad taste, and view of e-cigarettes as less satisfying than cigarettes). The survey data showed that the top reasons for experimentation were curiosity (54.4%), appealing flavors (43.8%), and peer influences (31.6%), and the top reasons for discontinuation were responses related to losing interest (23.6%), perceiving e-cigarettes as "uncool" (16.3%), and health concerns (12.1%). Cigarette smokers tried e-cigarettes because of the perceptions that they can be used anywhere and to quit smoking and discontinued because they were not as satisfying as cigarettes. School level differences were detected.

conclusionsE-cigarette prevention efforts toward youth should include limiting e-cigarette flavors, communicating messages emphasizing the health risks of use, and changing social norms surrounding the use of e-cigarettes. The results should be interpreted in light of the limitations of this study.

Indexed as

AdolescentAdolescent BehaviorAdultConnecticutElectronic Nicotine Delivery SystemsFemaleFlavoring AgentsFocus GroupsHumansMalePeer GroupSchoolsSmokingSmoking CessationStudentsSurveys and QuestionnairesFlavoring Agents

Identifiers

PMID25481917
PMCPMC4674436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.